Notification from Ivan Badinski under Art. 19 of Regulation (EU) No 596/2014 of October, 22 2018
Notification from Ognian Palaveev under Art. 19 of Regulation (EU) No 596/2014 of October, 22 2018
Notification from Vessela Stoeva under Art. 19 of Regulation (EU) No 596/2014 of October, 22 2018
Notification from Ognian Donev under Art. 19 of Regulation (EU) No 596/2014 of October, 22 2018
Notification for the distribution of bonus shares for the 85th anniversary of Sopharma AD
Sopharma AD (3JR: “BSE-Sofia” AD, SPH: Warsaw Stock Exchange) announces that yesterday it distributed 277 400 shares to 1 733 employees in compliance with the decision of the General Meeting of Shareholders of June 15, 2018 to distribute bonus shares among the employees of the Company for its 85th anniversary. The procedure involved training of all employees for the respective rights they would have as shareholders in the company. The shares of some employees on maternity / paternity leave or long-term sick leave have not yet been allocated.
Meeting with investors
Sopharma AD (3JR: “BSE-Sofia” AD, SPH: Warsaw Stock Exchange) kindly invites you to the Annual Investor Relations Meeting that will take place on November 16, 2018, starting at 13:30 in Sofia, 16, Rozhen Blvd., and will include a meeting with the management of the two companies and a visit to the Regional Distribution Center of Sopharma Trading AD automated with the KNAPP system.
Sopharma celebrates its 85th anniversary with a concert in Sofia’s Arena Armeetz hall
11 000 – employees, officials, partners all with their families have marked together the impressive milestone of the Bulgarian Group of companies
Notification on the terms and conditions for payment of the 6-month dividend for the first half of 2018
Sopharma AD (3JR: “BSE-Sofia” AD, SPH: Warsaw Stock Exchange) notifies that the Company will initiate dividend payment of the voted on the EGM held on September, 14 2018 dividend of 0.05 BGN on October, 22 2018.
The persons eligible for dividend are those present in the register of the Central Depository 14 days after the date of the AGM, i.e. September, 28 2018.
Sales revenues for September 2018
Sopharma AD (3JR: “BSE-Sofia” AD, SPH: Warsaw Stock Exchange) notifies that for September 2018 the Company recorded decrease of sales revenues of 7% compared to the same month of 2017, including 55% increase of domestic sales and a decrease of 28% of export sales.